Events Partner Content World Orphan Drug Congress USA Virtual 2021 World Orphan Drug Congress USA Virtual
Views & Analysis Global impact: How regulatory affairs is shaping development... When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront.
News EU stops short of vaccine export controls after summit The European Union has stopped short of export controls on vaccines after leaders met at a summit to discuss the issue of shortfalls in supply.
News NICE backs ovarian cancer and multiple myeloma combination d... NICE has recommended funding for two cancer drug combinations for ovarian cancer and multiple myeloma.
News NICE axes funding for MSD's Keytruda in bladder cancer despi... NICE has axed funding for MSD’s Keytruda for second-line advanced bladder cancer in final guidance, despite an appeal from the company.
News Novartis says £1.8m Zolgensma is model for gene therapy pric... Novartis has said its gene therapy pricing model, involving a steep one-off payment, could be a template for the hundreds of similar treatments that could follow its Zolgensma for Spinal Mu
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.